What do systematic reviews say?

Adverse events other than hypoglycaemia

Adverse events other than hypoglycaemia

Adverse events other than hypoglycaemia

Serious adverse events for all placebos · patients with mental health disorders

Adverse events associated with treatment · Adults with oral cavity or oropharyngeal cancer

Serious adverse events at 6 or 12 months · adults and children with strabismus

Adverse events in infants ‐ not measured · GORD in infants

Anxiety (adverse effect, post‐intervention) · adults (aged 16 years and over) with CF

Grades 3 and 4 adverse events · hospitalised individuals with COVID‐19 (moderate to severe disease)

Serious adverse events and complications · people with liver metastases

Serious adverse events or adverse events · people with asthma

Adverse events: important adverse events · seriously mentally ill people in hospital

Treatment cessation due to adverse events · CRRT

Serious adverse events (number of people) · people with liver cirrhosis and ascites

Adverse events 12 months postintervention · adults with refractory glaucoma

Serious adverse events (number of events) · people with primary biliary cholangitis

Serious adverse events (number of events) · people with primary biliary cholangitis

Serious adverse events (number of events) · people with primary biliary cholangitis

Serious adverse events (number of events) · people with primary biliary cholangitis

Serious adverse events (number of events) · people with primary biliary cholangitis